The significance of FOXP1 in diffuse large B-cell lymphoma.
about
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients.
P2860
The significance of FOXP1 in diffuse large B-cell lymphoma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The significance of FOXP1 in diffuse large B-cell lymphoma.
@ast
The significance of FOXP1 in diffuse large B-cell lymphoma.
@en
The significance of FOXP1 in diffuse large B-cell lymphoma.
@nl
type
label
The significance of FOXP1 in diffuse large B-cell lymphoma.
@ast
The significance of FOXP1 in diffuse large B-cell lymphoma.
@en
The significance of FOXP1 in diffuse large B-cell lymphoma.
@nl
prefLabel
The significance of FOXP1 in diffuse large B-cell lymphoma.
@ast
The significance of FOXP1 in diffuse large B-cell lymphoma.
@en
The significance of FOXP1 in diffuse large B-cell lymphoma.
@nl
P2860
P1433
P1476
The significance of FOXP1 in diffuse large B-cell lymphoma.
@en
P2093
Alison H Banham
Duncan M Gascoyne
P2860
P304
P356
10.1080/10428194.2016.1228932
P577
2016-09-27T00:00:00Z